Introduction
Most regulatory hiring niches in this field trace back to a scientific shift: a new modality, a new device architecture, a new therapeutic class. The over-the-counter hearing aid category is different. It came from a single rule change that moved a whole class of devices out of the traditional prescription-and-fitting model and into a self-selected, retail-shelf model. That single change has quietly built its own regulatory specialty, and it is worth understanding on its own terms if you work in medical device regulatory affairs or are looking for where the next few years of device hiring are headed.
What the OTC Hearing Aid Rule Actually Changed
Before the rule took effect, most hearing aids in the United States moved through a pathway that assumed a licensed professional would evaluate the patient, select the device, and fit it. FDA's final rule established a defined over-the-counter category for certain hearing aids intended for adults who perceive themselves to have mild to moderate hearing loss. Devices in that category can be sold directly to consumers, without a medical exam, a prescription, or fitting by an audiologist or hearing instrument specialist, provided they meet specific output and performance limits and certain labeling requirements.
That is a narrower and more technical change than headlines about "hearing aids without a prescription" suggest. The rule did not eliminate the prescription hearing aid category; it created a parallel one with its own device requirements, its own labeling rules, and its own line the manufacturer cannot cross without effectively re-classifying the product. Regulatory teams working in this space spend a meaningful share of their time on exactly where that line sits for a given product design.
Why It Created a Distinct Regulatory Track
A few things make OTC hearing aid regulatory work genuinely different from adjacent device work, rather than just "hearing aids, but easier."
First, the self-fitting requirement pushes technical and regulatory work together in a way that traditional prescription devices did not require. A device that lets a consumer set their own gain and frequency response without professional guidance has to demonstrate, through testing and labeling, that an untrained user can do this safely and effectively. That is a human factors and usability engineering problem as much as it is a classic device-performance problem, and it sits squarely in regulatory affairs' lane because it drives what claims and instructions the labeling can support.
Second, the category boundary is actively policed. A product that implies it treats hearing loss beyond mild-to-moderate, or that makes claims associated with a medical diagnosis, risks being treated as a prescription device or a misbranded product regardless of how it is marketed. Regulatory affairs professionals in this space spend real time on claims review, working closely with marketing, to keep promotional language inside the OTC lane.
Third, state law has not moved in lockstep with the federal rule. Hearing aid dispensing has historically been regulated at the state level, and the interaction between state dispensing statutes and the federal OTC category has required its own legal and regulatory reading in a number of states. A regulatory professional working for a company selling nationally needs at least a working fluency in that overlap, even if outside counsel does the deep state-law analysis.
The Skills This Niche Rewards
Companies building in this space are drawing regulatory talent from two directions: traditional medical device regulatory affairs, and consumer electronics/audio companies that are new to FDA-regulated products entirely. Neither background alone is a complete match, and the professionals who do well tend to have built a specific combination.
From the device side, what transfers is 21 CFR Part 800 familiarity, quality system experience, and comfort with performance standards and labeling review. From the consumer electronics side, what transfers is an instinct for how retail packaging, app-based interfaces, and self-service product experiences actually get built and shipped on consumer timelines, which tend to be faster than a device company used to a multi-year 510(k) cycle. The professionals who stand out are the ones who can hold both realities at once: a self-fitting app update is still a device change that may need to be assessed under the quality system, even though the product team is thinking about it as a routine software release.
Human factors and usability engineering literacy is close to a hard requirement here, not a nice-to-have. If you have not worked directly on formative or summative usability studies, understanding how those studies are designed and what they need to demonstrate for a self-fitting claim is worth building deliberately, because it comes up constantly in this niche.
Who Is Hiring
Demand shows up in a few different places. Established hearing health companies that historically sold only through audiologists have needed regulatory capacity to build and defend an OTC product line alongside their prescription business, which is a different labeling and claims discipline than they had built internally. Consumer electronics and audio companies entering hearing health for the first time need regulatory affairs hired essentially from zero, often as one of their first regulatory hires, which means the role tends to be broader and more foundational than a specialist role at a mature device company. And a smaller set of new entrants — companies built specifically around the OTC category — need regulatory leadership from day one to shape the product roadmap around what the labeling and testing requirements will actually support.
That last group is worth flagging for job seekers specifically: an early regulatory hire at a company built around this category has outsized influence on product decisions, because the OTC boundary constrains what the device is allowed to do in a way that touches engineering, marketing, and go-to-market planning all at once.
How the International Picture Differs
Companies that sell hearing devices globally cannot simply extend the US OTC framework abroad and assume it transfers cleanly. Other major markets have historically taken a more conservative view of self-fitting hearing devices, and the professional-fitting expectation embedded in many other regulatory systems has not moved at the same pace as the US rule. A device engineered to satisfy the US self-fitting requirements may need a different labeling strategy, a different claims structure, or in some cases a genuinely different product configuration to be sold as an OTC-equivalent product elsewhere, and in some markets no true OTC-equivalent pathway exists at all, meaning the device has to compete through the traditional prescription and professional-fitting channel regardless of how it was built for the US market.
This matters for regulatory professionals building a career in this niche because it means the US rule, however significant domestically, is not the end of the regulatory story for a company with global ambitions. Understanding how to sequence global regulatory strategy around a device that is genuinely OTC in one major market and effectively prescription-equivalent in another is a specific and transferable skill, and it is one that shows up disproportionately in interviews for regulatory leadership roles at companies trying to scale an OTC hearing product internationally rather than just launch it domestically.
How to Position Yourself
If this niche interests you and you are coming from traditional device regulatory affairs, the fastest way to build credibility is to get hands-on with a real OTC hearing aid product's labeling and packaging, even informally. Read the instructions for use as a usability document, not just a compliance artifact, and think through where a first-time user without professional guidance could misuse the device. That kind of applied thinking is what interviewers in this space are trying to surface, far more than familiarity with the regulation's text itself.
If you are coming from consumer electronics without prior FDA experience, the highest-leverage investment is building real familiarity with the quality system regulation and with how a design history file gets built and maintained, since that is the part of the job that will not resemble anything in your consumer product background. Pair that with reading FDA's own guidance and public communications on the OTC hearing aid category closely; the agency has been unusually explicit about its reasoning for this rule, and understanding that reasoning helps you talk credibly about the boundary between OTC and prescription in an interview. It is also worth spending time with FDA's warning letters and public enforcement actions in adjacent consumer health device categories, since the agency's stated reasoning in those actions is often the clearest available signal of where the practical line between permitted and impermissible claims actually sits.
It is also worth building a working vocabulary in the adjacent regulatory questions this category tends to raise even when they are not, strictly speaking, part of the hearing aid rule itself. Bluetooth-enabled hearing devices that stream audio or connect to a companion app raise data privacy and cybersecurity questions that increasingly show up in FDA's expectations for connected devices generally. A candidate who can speak to how software updates, app permissions, and audio data handling intersect with the device's regulatory status stands out in a hiring process that is often looking for someone who will not need months of ramp-up before contributing on the parts of the product that are not, strictly, "the hearing aid part."
Either way, resist treating this as a simplified, lower-stakes corner of device regulatory affairs. It has fewer historical precedents to lean on than mainstream device categories, which means more of the interpretive work — where exactly does a claim cross a line, what does "adequate" self-fitting guidance actually require — falls on the regulatory professional rather than on established convention. That is exactly why it is a good place to build a distinctive specialty, and why regulatory professionals who get in early tend to become the internal reference point their company turns to as the category matures, rather than one voice among many on an established product line.
Conclusion
The OTC hearing aid rule is a useful case study in how a single classification change can open a durable regulatory hiring niche, distinct from the therapeutic-area and technology-driven niches that dominate most discussion of where device regulatory jobs are headed. It rewards people who can combine classic device regulatory discipline with real fluency in usability and consumer product realities, and it currently has more open interpretive ground than most established device categories. For regulatory professionals looking for a specific, learnable edge in medical device hiring, it is worth a closer look.